Urgent

Acute tubular necrosis (ATN) — ischaemic & nephrotoxic intrinsic AKI

Acute kidney injury · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Commonest cause of intrinsic (renal) AKI: tubular epithelial injury from sustained prerenal ischaemia (sepsis, hypotension, major surgery, hypovolaemia) or nephrotoxins (aminoglycosides, amphotericin, cisplatin, iodinated contrast, myoglobin/haemoglobin, light chains). Characterised by muddy-brown granular/tubular epithelial casts, FENa typically >1-2%, failure to respond to fluid challenge, and a course of oliguria/maintenance then polyuric recovery over days-weeks. Management is supportive — remove the insult, optimise perfusion, avoid further nephrotoxins, and support with RRT as needed; there is no proven pharmacological reversal.

Red flags

  • Refractory hyperkalaemia with ECG changes, severe acidosis or pulmonary oedema — emergency RRT
  • Anuria (suggests obstruction, cortical necrosis or vascular occlusion — re-image)
  • RBC casts/dysmorphic haematuria or haemoptysis — this is not ATN; think RPGN/vasculitis, urgent biopsy
  • Rising CK with tea-coloured urine (rhabdomyolysis) — aggressive fluids
  • No recovery beyond 3-6 weeks — reconsider diagnosis and biopsy

Assessment

Differential diagnosis

  • Prerenal AKI (responds to fluids, FENa <1%, bland sediment) — the precursor on the same continuum
  • Acute interstitial nephritis (drug rash, eosinophilia, WBC casts, sterile pyuria)
  • Postrenal/obstructive AKI (hydronephrosis on USS)
  • Rapidly progressive GN / vasculitis (haematuria, RBC casts, systemic features)
  • Contrast-associated AKI, pigment nephropathy (rhabdomyolysis/haemolysis), cast nephropathy (myeloma), TMA/HUS/TTP
  • Atheroembolic (cholesterol emboli) disease post-procedure

Investigations

  • U&E, creatinine/eGFR trend, bicarbonate, potassium, phosphate, calcium, uric acid
  • Urine microscopy (muddy-brown granular and renal tubular epithelial cell casts) and urine dip
  • Urine + serum osmolality, urine sodium; FENa (>2% supports ATN; FEurea <35% if on diuretics)
  • FBC, CK (rhabdomyolysis), LDH/haptoglobin/blood film (haemolysis/TMA), CRP/cultures (sepsis)
  • Renal tract ultrasound (exclude obstruction; normal/large kidneys)
  • Drug/nephrotoxin and contrast exposure review; where cause unclear or no recovery: myeloma screen, immunology (ANA/ANCA/anti-GBM/complement), consider biopsy
  • VBG, fluid balance/weights, urinary catheter for accurate output if critically ill

Management

  • Resuscitate circulation: restore euvolaemia with balanced crystalloid; treat sepsis and hypotension (vasopressors to MAP ~65 mmHg if fluid-replete) to restore renal perfusion
  • Identify and remove the insult — stop aminoglycosides/NSAIDs/ACEi/ARB/contrast and other nephrotoxins; relieve any obstruction
  • Confirm it is established ATN (no response to adequate fluid challenge, muddy-brown casts) rather than ongoing prerenal — avoid repeated fluid boluses once euvolaemic/overloaded
  • Dose-adjust all renally cleared drugs to current eGFR; avoid gadolinium/iodinated contrast where possible
  • Manage complications: hyperkalaemia, acidosis, fluid overload (diuretics only to manage volume — they do NOT treat ATN or improve renal outcome), hyperphosphataemia
  • Nutrition and avoid hypovolaemia/second hits; monitor for the polyuric recovery phase with large urine output and K+/Mg2+/phosphate losses — replace electrolytes
  • Start RRT for refractory hyperkalaemia, severe acidosis, refractory fluid overload/pulmonary oedema, or uraemic complications (AEIOU) — not for an isolated urea/creatinine number

Drugs & doses

Balanced crystalloid (Hartmann's/Plasma-Lyte) IV titrated to euvolaemia — NOT fixed large volumes once filled
Noradrenaline IV infusion titrated to MAP ~65 mmHg if hypotensive despite fluids (ICU) [verify local dose]
Furosemide 40-80 mg IV for symptomatic fluid overload only (manages volume, does not shorten ATN); avoid routine 'renal-dose' use [verify local dose]
Hyperkalaemia bundle: calcium gluconate 10% 10-30 mL IV (cardioprotection) + insulin 10 units in 25 g glucose IV + salbutamol 10-20 mg nebulised [verify local dose]
Sodium bicarbonate — reserve for severe metabolic acidosis/hyperkalaemia per local protocol [verify local dose]
Avoid: aminoglycosides, NSAIDs, ACEi/ARB, iodinated/gadolinium contrast during active injury
Note: low-dose dopamine, mannitol and loop diuretics do NOT prevent or treat ATN and should not be used for that purpose

Disposition

Admit under medicine/nephrology; critical care for shock, refractory hyperkalaemia/acidosis or need for RRT. Most ischaemic/nephrotoxic ATN recovers over days-weeks with supportive care; arrange renal follow-up as AKI is a risk factor for later CKD.

Complications & pitfalls

  • Hyperkalaemia, metabolic acidosis, fluid overload/pulmonary oedema, uraemia
  • Polyuric recovery phase with hypokalaemia, hypomagnesaemia, hypophosphataemia and volume depletion
  • Protracted or incomplete recovery; progression to CKD, occasionally dialysis dependence
  • Nosocomial infection and drug toxicity from failure to renally dose
  • Uraemic pericarditis/encephalopathy if untreated

Exam pearls

  • ATN is a clinical/urinary diagnosis: muddy-brown granular casts + FENa >1-2% + no response to fluids distinguishes it from prerenal AKI, which is the same injury caught earlier and reversible.
  • Diuretics convert oliguric to non-oliguric states for fluid management only — they do not improve survival or renal recovery; never use them to 'treat' the AKI.
  • RRT indications are the complications (AEIOU: Acidosis, Electrolytes/K+, Intoxication, Overload, Uraemia), not an absolute creatinine.
  • Watch the recovery (polyuric) phase: patients can become profoundly volume- and electrolyte-depleted — replace losses, do not under-resuscitate.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.